LLY

Eli Lilly and Company discovers, develops, manufactures, and markets human pharmaceutical products in the United States, Europe, China, Japan, and internationally. The company offers cardiometabolic health products, including Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity.

Eli Lilly and Company (LLY) is a healthcare company listed on NYSE, traded in USD. Over the past year it moved between $850.51 and $1,449.68, and it pays a dividend every quarter.

• Healthcare
• Drug Manufacturers - General
• Indianapolis, United States
• 50K employees
• Led by David A. Ricks